Meet Your Medication:
Semaglutide & Tirzepatide
What is GLP-1?
Semaglutide is a GLP-1 medicine. It’s the active ingredient in Wegovy® (for long-term weight management) and Ozempic® (for type 2 diabetes). Both are trademarks of Novo Nordisk.
How it helps (in simple terms):
-
Helps your body release insulin when blood sugar is high
-
Lowers glucagon, a hormone that can raise blood sugar
-
Slows stomach emptying, so sugar enters the blood more gradually
-
Reduces appetite, helping you feel full sooner
Why that matters (benefits):
-
Better blood-sugar control
-
Meaningful weight loss when used as prescribed and paired with healthy habits
About our compounded option:
For eligible patients with a valid prescription, we offer compounded semaglutide for injection from an FDA-registered 503B outsourcing facility that follows cGMP quality standards.
Important note:
Compounded medications are not FDA-approved. They’re prepared to meet specific patient needs and are provided in line with applicable federal and state regulations. Always talk with your healthcare provider to see if this is right for you.
Wondering if GLP-1 is Right for You?
Ready to take the first step toward a healthier you? Click below to schedule your call—our licensed care team will review your goals, discuss safe evidence-based options (including GLP-1 therapy when appropriate), outline transparent pricing, and coordinate fast pharmacy fulfillment through HIPAA-compliant workflows. Your path to feeling better starts with one conversation—book now.
.png)